Read up on our latest news

Featured Story

Mirvie Founders
Mirvie Raises $60 Million For Blood Test To Predict Pregnancy Complications
May 17, 2022
The company announced it raised $60 million in Series B funding led by Decheng Capital. BlackRock, Foresite Capital, General Catalyst, GV, Khosla Ventures, and Mayfield participated in the round. Olympic runner Allyson Felix, whose daughter was born eight weeks early due to preeclampsia complications, also invested in the round. The company has raised a total of $90 million to date.
Read more
Stst Logo
Mirvie Raises $60 Million For Blood Test To Predict Pregnancy Complications
May 17, 2022
The company announced it raised $60 million in Series B funding led by Decheng Capital. BlackRock, Foresite Capital, General Catalyst, GV, Khosla Ventures, and Mayfield participated in the round. Olympic runner Allyson Felix, whose daughter was born eight weeks early due to preeclampsia complications, also invested in the round. The company has raised a total of $90 million to date.
Read more
Mirvie Founders

Media Coverage

press logo
The future of pregnancy health: prediction and prevention
March 27, 2024
If doctors had better tools to understand each pregnancy’s biology, they could then help moms and babies achieve better outcomes.
Read more
press logo
Research highlights strong demand for data on personalized risk of preeclampsia
March 19, 2024
New research from Mirvie highlights significant demand for predictive testing for pregnancy complications like preeclampsia.
Read more
press logo
Preeclampsia & other pregnancy complications: What women need to know
April 2, 2024
Dr. Alison Cowan of Mirvie shares the facts behind common pregnancy complications and how women can advocate for themselves during pregnancy.
Read more
press logo
Mirvie announces landmark study on pregnancy complications
November 16, 2023
The US pregnancy platform Mirvie has completed enrolment of its 10,000 person research study on pregnancy complications. The study seeks to understand how RNA messages found in expectant mothers’ blood can predict life-threatening pregnancy complications.
Read more
press logo
Dr. Alison Cowan and using diagnostics to save women in pregnancy
October 10, 2023
Mirvie is changing the game for moms through their use of RNA testing to diagnosis potential pregnancy complications like pre-eclampsia, pre-term birth, and gestational diabetes earlier.
Read more
press logo
Exceder Biotech Startups Podcast
October 23, 2023
Finding & Addressing Unmet Needs | The Maternal Health Crisis | Creating an Empathy-Focused Company Culture | Fundraising & Hitting Milestones in a Recession
Read more
press logo
The urgent call for innovation and investment in maternal health
October 28, 2023
Women’s health remains one of the most underfunded, under-researched, and underserved areas of investment and study.
Read more
press logo
What does venture capital have against femtech?
September 28, 2023
Tech companies building products that focus on women’s health still struggle to attract VC funding.
Read more
press logo
A Genetic Snapshot Could Predict Preterm Birth
Doctors are trying out a simple blood test to screen for some common pregnancy complications.
Read more
press logo
Preventing maternal mortality: We need data to truly understand maternal health in the US
January 23, 2023
We often speak about the rising maternal mortality rate, but then we fail to dig into its underlying causes. We lack standardized reporting systems, such that different states track different outcomes using entirely different systems. We must view this as not only an opportunity for awareness, but also for action.
Read more
A personalized window
into pregnancy health.
650-741-6510
651 Gateway Boulevard, Suite 1200
South San Francisco, California 94080
References
Terms of Service
Privacy Policy
©2025 Mirvie, Inc. All rights reserved.